Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Circulating Cell-Free Tumour DNA in the Management of Cancer.

International journal of molecular sciences - 19 Jun 2015

Francis Glenn, Stein Sandra

Abstract excerpt

With the development of new sensitive molecular techniques, circulating cell-free tumour DNA containing mutations can be identified in the plasma of cancer patients. The applications of this technology may result in significant changes to the care and management of cancer patients. Whilst, currently, these "liquid biopsies" are used to supplement the histological diagnosis of cancer and metastatic disease, in the...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Neoplasms
Share to Neoplastic Cells, Circulating
Share to Biomarkers, Tumor

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Cancer Genomics and Diagnostics

Share to Disease Progression

Share to DNA, Neoplasm

Share to Lung Cancer Treatments and Mutations

Share to Mutation

Source

Open in PubMed Open full text

Identifiers

PMID: 26101870
DOI: 10.3390/ijms160614122
PMCID: PMC4490543

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Circulating Cell-Free Tumour DNA in the Management of Cancer.PMID 26101870Read ↗

Circulating tumour DNA as a cancer biomarker.Semantic proximity Read ↗

Circulating Tumor DNA in Cancer Management.Semantic proximity Read ↗

Liquid biopsies come of age: towards implementation of circulating tumour DNA.Semantic proximity Read ↗

Cell-free DNA in cancer: current insightsSemantic proximity Read ↗

The translational potential of circulating tumour DNA in oncology.Semantic proximity Read ↗

Cell‐free circulating tumour DNA as a liquid biopsy in breast cancerSemantic proximity Read ↗

Advances in Circulating Tumor DNA Analysis.Semantic proximity Read ↗

Cell-free circulating tumor DNA profiling in cancer managementSemantic proximity Read ↗

Genotyping cell-free tumor DNA in the blood to detect residual disease and drug resistance.Semantic proximity Read ↗

Toward liquid biopsies in cancer treatment: application of circulating tumor DNASemantic proximity Read ↗

Circulating tumor DNA-From bench to bedside.Semantic proximity Read ↗

Circulating biomarkers to monitor cancer progression and treatmentSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.